Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc (JAZZ)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
247. 53
+5.35
+2.2091%
$
14.95B Market Cap
17.91 P/E Ratio
- Div Yield
503,600 Volume
18.96 Eps
$ 242.18
Previous Close
Add Transaction
Day Range
238.08 249.5
Year Range
105 250.49
Want to track JAZZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Jazz Pharmaceuticals plc (JAZZ) Statistics

Valuation metrics

Market Cap 14.95B
Enterprise value 19.12B
Trailing P/E (ttm) 603.73
Forward P/E -
PEG ratio -2.04
Price/Sales (ttm) 3.5
Price/Book (mrq) 3.38
Enterprise Value/Revenue 4.31
Enterprise Value/EBITDA 35.14

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 405.33K
Average volume (90 days) 894.54K

Price summary

52-Week low 105
52-Week high 250.49
Beta -
50-Day moving average 231.59
200-Day moving average 193.66

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.01%
Operating margin 0.11%

Operational effectiveness

Return on assets 0%
Return on equity 0.01%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 71.71
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.48
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 46.43
Total debt (mrq) -
Total Debt/Equity (mrq) 1.2
Current ratio (mrq) 2.04%
Book value per share (mrq) 73.22

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -